Literature DB >> 5814426

Bioassay for hamycin and amphotericin B in serum and other biological fluids.

S Shadomy, J A McCay, S I Schwartz.   

Abstract

A bioassay suitable for measuring concentrations of the polyene antifungal agents hamycin and amphotericin B in biological fluids is described. By using Paecilomyces varioti as the indicator organism, sensitivity of the bioassay was found to be in the range of 0.01 to 0.02 mug/ml. A linear dose-response curve was obtained with amphotericin B; the curve for hamycin was curvilinear. In a series of assays, hamycin serum levels in the range of 0.01 to 3.5 mug/ml were measured; with amphotericin B, serum levels in the range of 0.015 to 0.175 mug/ml were measured in patients receiving orthodox intravenous medication and as high as 9.0 mug/ml in one patient treated with extraordinarily high doses of the drug.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5814426      PMCID: PMC377729          DOI: 10.1128/am.17.4.497-503.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  4 in total

1.  Bioassay of the antifungal agent X-5079C in serum of patients.

Authors:  C W EMMONS; W R PIGGOTT
Journal:  Am Rev Respir Dis       Date:  1961-10

2.  Amphotericin B and other polyene antifungal antibiotics: photometric assay and factors influencing activity.

Authors:  J R GERKE; M E MADIGAN
Journal:  Antibiot Chemother (Northfield)       Date:  1961-04

3.  Cylinder plate assays for amphotericin B in dosage forms and body fluids.

Authors:  J KRAMER; A KIRSHBAUM
Journal:  Antibiot Chemother (Northfield)       Date:  1960-03

4.  Bioassay for hamycin.

Authors:  W R Piggott; T W Williams; C W Emmons
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965
  4 in total
  18 in total

1.  Stability of amphotericin B in fungal culture media.

Authors:  S C Cheung; G Medoff; D Schlessinger; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Joseph Meletiadis; Rafal Al-Saigh; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides; Loukia Zerva
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Radiometric determination of the concentration of amphotericin B in body fluids.

Authors:  R L Hopfer; D Gröschel
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

Review 4.  Chemistry and biology of the polyene macrolide antibiotics.

Authors:  J M Hamilton-Miller
Journal:  Bacteriol Rev       Date:  1973-06

5.  Characterization of the binding of amphotericin B to Saccharomyces cerevisiae and relationship to the antifungal effects.

Authors:  J Kotler-Brajtburg; G Medoff; D Schlessinger; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  Microassay foramphotericin B.

Authors:  R M Bannatyne; R Cheung; H R Devlin
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

7.  Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B.

Authors:  A S Bayer; J E Edwards; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Amphotericin B therapy in an anephric patient.

Authors:  H A Feldman; J D Hamilton; R A Gutman
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

9.  Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys.

Authors:  W E Bullock; R G Luke; C E Nuttall; D Bhathena
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Rafal Al-Saigh; Maria Siopi; Nikolaos Siafakas; Aristea Velegraki; Loukia Zerva; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.